BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3103545)

  • 1. [Concentration of 5-FU and tegafur in the ascites fluid in patients with peritonitis carcinomatosa after UFT oral administration].
    Seki H; Takahashi H; Kimura K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):747-8. PubMed ID: 3103545
    [No Abstract]   [Full Text] [Related]  

  • 2. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood and tumor levels of tegafur, 5-fluorouracil, and uracil].
    Takeshita T; Iwasaki M; Narita M; Sou M; Sato M; Hashimoto T; Kameya S; Iigima N
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3053-8. PubMed ID: 3142365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
    Shimoyama T; Shimizu T; Kusano H; Ishikawa H; Miyashita K; Nakazaki T; Yasutake T; Yoshida A; Yoshida K; Ogawa T
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
    Fujita K; Munakata A
    Int J Clin Pharmacol Res; 1991; 11(4):171-4. PubMed ID: 1813435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
    Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-FU pharmacokinetic study of 5-FU hepato-arterial infusion with oral UFT].
    Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natui S
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2109-11. PubMed ID: 12484014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
    Sekiguchi I; Suzuki M; Tamada T; Nishida M
    Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].
    Shinoda I; Takahashi Y; Takeuchi T; Kuriyama M; Ban Y; Kawada Y; Ito Y; Yamamoto N; Maeda S; Tada K
    Hinyokika Kiyo; 1991 Jul; 37(7):711-5. PubMed ID: 1927771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
    Nakamura T; Shimada K; Okubo Y; Tanaka S; Tanabe S; Yoshida M; Doi K; Uchinami M; Horiuchi T; Tanaka K
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1423-6. PubMed ID: 15446570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM; Pazdur R; Benner SE; Canetta R
    Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
    Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
    Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
    Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].
    Fukunaga H; Katsumi M; Aoki Y; Oka S; Konishi R; Yukawa H; Kawaguchi T; Tamaki Y; Takifuji K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2735-9. PubMed ID: 3115184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [5-FU concentration in the serum and the tumor tissue after administration of UFT 200 mg/day to patients over 80 years of age with oral cancer].
    Iida A; Takagi R; Hoshina H; Ono K; Kaji M; Tsurumaki H; Fukuda J; Nagashima K; Miyaura Y; Hayatsu M; Miyamoto T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1527-32. PubMed ID: 11015997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
    Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.